Budget proposes Rs 10,000 cr investment in biopharma over next 5 years
Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the countrys pharmaceuticals industry. She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.
- Country:
- India
Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the country's pharmaceuticals industry. Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis. She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology. The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property). The India Semiconductor Mission (ISM) is a specialized, autonomous business division within Digital India Corporation under Ministry of Electronics and Information Technology (MeitY), designed to build a sustainable semiconductor and display ecosystem. Sitharaman also announced support for mineral rich states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to establish critical mineral facilities. She added that 'Sabka Saath, Sabka Vikas' is the third Kartavya of the government.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Govt will create five tourism destinations in 5 Purvodaya states and will make provisions for 4,000 e-buses: FM.
Threshold for availing safe harbour for IT services is being enhanced from Rs 300 crore to Rs 2,000 crore: FM.
Govt proposes to top up Self Reliant India Fund with Rs 4,000 cr in 2026-27 to support MSMEs
Anthem Biosciences, Biocon stock jumps as Budget proposes Rs 10K cr investment in biopharma
Govt to create network of over 1,000 accredited clinical trial sites, says FM

